The following information is from Children’s Health Defense. A major investigation has found that the Food and Drug Administration (FDA) repeatedly overlooked serious safety violations at Sun Pharma’s factory in Halol, India, one of the world’s largest suppliers of generic drugs […]
FDA turns ‘blind eye’ to safety violations as Indian drugmaker ships generics to US Read More »
From blue skin to thigh bone fractures, we discuss unexpected, wild, side effects from common medicines. Listen below:
50 Bizarre Side Effects from Common Medicine (Podcast) Read More »
The following is from Children’s Health Defense. A new two-year investigation by The Lever finds that the US Food and Drug Administration (FDA) approved hundreds of drugs over the past decade without reliable evidence they work. Many of those drugs are still
FDA approved hundreds of drugs without evidence they work Read More »
The following is from MedPage Today. The FDA has added a boxed warning to fezolinetant (Veozah), a hormone-free treatment for menopause-related hot flashes, citing the risk of rare but severe liver injury. The warning follows an initial drug safety communication
(READ) FDA adds Boxed Warning to hot flash drug Read More »
The following information is from Children’s Health Defense. A new report links the death of a Scottish nurse to Mounjaro, a weight-loss drug from Eli Lilly that belongs to the GLP-1 receptor agonist class. This drug category, including Novo Nordisk’s Ozempic and Wegovy, works by
FDA-approved weight-loss drug linked to nurse’s death Read More »
The following information is from Public Citizen. Public Citizen, a nonprofit consumer advocacy organization, is calling for federal officials to investigate troubling practices in recent Alzheimer’s disease drug trials. A New York Times report reveals that participants in trials for two drugs—lecanemab
Patients in Alzheimer’s Drug Trials Not Told About Risks Read More »
